DigestRedComo funciona
Red
/
Empresas
Ob
No verificado

Obsidian Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosOncologíaSalud

11 Comunicados de prensa

Ver todos los comunicados de prensa
21/04/2026
Eventos
Finanzas
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Obsidian Therapeutics to Present OBX-115 Phase 2 Clinical Data in Advanced Melanoma in Oral Presentation at 2026 ASCO Annual Meeting
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0
14/04/2026
Mercado de valores
Mercado laboral
Biotecnología
Farmacéutica
Salud
Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0
12/01/2026
Mercado laboral
Biotecnología
Farmacéutica
Salud
Obsidian Therapeutics Appoints Julie Feder as Chief Financial Officer
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0
02/06/2025
Oncología
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Eventos
Industria
Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma in Ongoing Multicenter Study at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0
28/04/2025
Eventos
Ferias y Congresos
Industria
Salud
Biología
Biotecnología
Medicina - Varios
Farmacéutica
Obsidian Therapeutics to Present Preclinical Data Supporting Novel Application of cytoDRiVE® Platform at the American Society of Gene and Cell Therapy Annual Meeting
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0
25/04/2025
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Obsidian Therapeutics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0
23/04/2025
Industria
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Oncología
Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Patients with Advanced Melanoma in Oral Presentation at the 2025 ASCO Annual Meeting
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0
06/01/2025
Eventos
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Obsidian Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0
05/11/2024
Ferias y Congresos
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Obsidian Therapeutics to Present Preclinical Data Supporting OBX-115 and cytoDRiVE® Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0
03/09/2024
Ciencia
Biotecnología
Oncología
Sanidad
Salud
Higiene alimentaria
Industria
Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma
Fuente
Obsidian Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0